Clinical trial
Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque…
NCT00408187 · Aurinia Pharmaceuticals Inc., Industry · Completed
Key facts
| NCT number | NCT00408187 |
|---|---|
| Title | Randomized, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients |
| Official title | A Phase III, Randomized, Multicentre, Double-Blind, Placebo and Ciclosporin Controlled Study of ISA247 in Plaque Psoriasis Patients |
| Acronym | ESSENCE |
| Lead sponsor | Aurinia Pharmaceuticals Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | voclosporin, Ciclosporin, Placebo |
| Enrollment | 642 |
| Start date | Dec 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Dec 6, 2006 |
| Last update posted | Jul 30, 2009 |
| Countries | Canada, Germany, Poland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: